Preliminary Final Report
Preliminary Final Report
Perth, Aug 30, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to confirm the lodgement of the MMJ Appendix 4E for the financial year ended 30 June 2018 (as attached to this announcement).

The 2018 MMJ Annual Report including audited financial statements will be lodged during September 2018.

The Appendix 4E is also available on MMJ's website: mmjphytotech.com.au

Comments

The profit for the consolidated entity after providing for income tax and non-controlling interest amounted to $34,119,000 (30 June 2017: loss of $12,725,000).

On 10 October 2017, MMJ first announced its intention to begin shifting its operational focus toward that of a global cannabis investment company, targeting the full range of emerging cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, research & development, hemp food products and retail.

To view the full report, please visit:
http://abnnewswire.net/lnk/N6HK05U9


About MMJ PhytoTech Ltd

Phytotech Medical ASX:PYL

MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

      


Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



Related Companies

MMJ PhytoTech Ltd   

ABN Newswire This Page Viewed:  (Last 7 Days: 63) (Last 30 Days: 204) (Since Published: 1801) 
ANALYTICS: LOGIN HERE

MMJ PhytoTech Ltd NEWS: RECENT VISITS (49655)

Research Report

Social Media